Organism name | Beta vulgaris |
---|---|
Genus | Beta |
Family | Chenopodiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Beta vulgaris |
---|---|
Linked NCBI taxonomy ID | 161934 |
Linked level | species |
Family in NCBI taxonomy | Amaranthaceae |
---|---|
ID | 3563 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00014091
![]() |
Vitexin 6''-O-malonyl 2''-O-xyloside
|
No. 1 | No. 15 |
![]() |
||||
C00038590
![]() |
Betavulgaroside III
|
No. 9 | No. 51 |
![]() |
||||
C00038591
![]() |
Betavulgaroside V
/ (+)-Betavulgaroside V |
No. 9 | No. 51 |
![]() |
||||
C00048504
![]() |
Pennogenin 3-O-beta-chacotrioside
/ (-)-Pennogenin 3-O-beta-chacotrioside |
CHEMBL501681
|
No. 17 | No. 11 |
![]() |
|||
C00048333
![]() |
Bethoside B
/ (-)-Bethoside B |
No. 17 | No. 11 |
![]() |
||||
C00048513
![]() |
Polygonatoside B3
/ (-)-Polygonatoside B3 |
CHEMBL478738
|
No. 17 | No. 11 |
![]() |
|||
C00003585
![]() |
Protodioscin
/ 3beta,22alpha,26-Trihydroxyfurost-5-ene-3-O-beta-chacotrioside-26-O-beta-D-glucopyranoside |
CHEMBL1163175
CHEMBL1981285 CHEMBL1995734 |
No. 21 | No. 11 |
![]() |
|||
C00048332
![]() |
Bethoside A
/ (-)-Bethoside A |
No. 21 | No. 11 |
![]() |
||||
C00002509
![]() |
Betavulgarin
/ 2'-Hydroxy-5-methoxy-6,7-methylenedioxyisoflavone |
No. 27 | No. 15 |
![]() |
||||
C00009856
![]() |
Irisone B
/ 5,2'-Dihydroxy-6,7-methylenedioxyisoflavone |
CHEMBL443974
|
C053588
|
No. 27 | No. 15 |
![]() |
||
C00002508
![]() |
Anhydroglycinol
/ 3,9-Dihydroxypterocarpene |
No. 27 | No. 15 |
![]() |
||||
C00003538
![]() |
Silphioside F
/ Calenduloside E / (+)-Silphioside F / (+)-Calenduloside E / Oleanoic acid 3-O-glucuronide |
CHEMBL446866
CHEMBL1974914 |
No. 50 | No. 51 |
![]() |
|||
C00003666
![]() |
Polypodine B
|
CHEMBL522181
CHEMBL502028 CHEMBL1567145 |
1 / 1 / 0 | No. 58 | No. 11 |
![]() |
||
C00000942
![]() |
Betagarin
|
No. 77 | No. 14 |
![]() |
||||
C00001263
![]() |
Octacosan-1-ol
|
CHEMBL1951714
|
C044309
|
No. 115 |
![]() |
|||
C00048334
![]() |
Bethoside C
/ (-)-Bethoside C |
No. 182 |
![]() |
|||||
C00001162
![]() |
Galactinol
|
No. 423 | No. 73 |
![]() |
||||
C00001430
![]() |
Skatole
|
CHEMBL1329793
|
D012862
|
2 / 1 / 4 | 7 / 1 | No. 710 | No. 4 |
![]() |
C00001606
![]() |
Prebetanin
|
No. 763 | No. 71 |
![]() |
||||
C00001584
![]() |
Betanin
|
CHEMBL1172614
|
C020228
|
0 / 2 | No. 763 | No. 71 |
![]() |
|
C00000096
![]() |
9-Ribosyl-trans-zeatin
/ Zeatin-9-beta-D-ribofuranoside |
No. 989 |
![]() |
|||||
C00001590
![]() |
Humilixanthin
|
No. 1220 | No. 71 |
![]() |
||||
C00001607
![]() |
Vulgaxanthin I
|
C018416
|
No. 1220 | No. 71 |
![]() |
|||
C00001608
![]() |
Vulgaxanthin-II
|
No. 1220 | No. 71 |
![]() |
||||
C00002743
![]() |
Ferulic acid
/ 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid |
CHEMBL32749
|
C004999
|
110 / 52 / 40 | 16 / 6 | No. 1366 | No. 6 |
![]() |
C00001343
![]() |
L-Azetidine 2-carboxylic acid
|
CHEMBL33592
CHEMBL1165239 CHEMBL1599178 |
C089382
|
8 / 14 / 15 | No. 1523 | No. 1 |
![]() |
|
C00002735
![]() |
Dihydrocaffeic acid
|
CHEMBL136927
|
C000995
|
1 / 2 / 0 | 1 / 1 | No. 1584 |
![]() |
|
C00001184
![]() |
Glutaric acid
|
CHEMBL1162495
|
C035736
|
3 / 0 / 0 | 2 / 0 | No. 1853 |
![]() |
|
C00001178
![]() |
Adipic acid
|
CHEMBL1157
|
C029900
|
4 / 14 / 11 | 1 / 0 | No. 1853 |
![]() |
|
C00000094
![]() |
2iP
/ N6-(delta2-Isopentenyl)adenine |
CHEMBL476189
|
C001478
|
5 / 2 / 3 | 18 / 0 | No. 2879 |
![]() |
|
C00000113
![]() |
Indole-3-carboxylic acid
|
CHEMBL387527
|
C012382
|
1 / 3 / 4 | No. 3632 |
![]() |
||
C00001151
![]() |
Sucrose
/ (+)-Sucrose |
CHEMBL253582
CHEMBL1976550 |
D013395
|
1 / 0 / 0 | 4 / 10 | No. 3949 |
![]() |
|
C00008598
![]() |
3,5-Dihydroxy-6,7-methylenedioxyflavanone
|
CHEMBL1802148
|
No. 4289 |
![]() |
||||
C00001193
![]() |
Malonic acid
|
CHEMBL7942
|
C030290
|
6 / 1 / 5 | 1 / 2 | No. 5377 |
![]() |
|
C00001582
![]() |
Betalamic acid
|
CHEMBL2062984
|
C000252
|
No. 7291 | No. 71 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000094 C00001343 C00002743 | 1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000094 C00001343 C00002743 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000094 C00001343 C00002743 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000094 C00001343 C00002743 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000094 C00001343 C00002743 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001430 C00002743 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001178 C00001343 | 11 / 10 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002743 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002743 | 3 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002743 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002743 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002743 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002743 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002743 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002743 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002743 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002743 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001178 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002743 | 2 / 2 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00001430 | 1 / 4 |
Q99489 | D-aspartate oxidase | Enzyme | C00001193 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00002743 | 2 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002743 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001178 | 3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002743 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002743 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002743 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002743 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002743 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002743 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002743 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00001151 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00003666 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002743 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002743 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002743 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002743 | 2 / 2 |
P14920 | D-amino-acid oxidase | Enzyme | C00001193 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00001343 | 1 / 2 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002743 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002743 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002743 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002743 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002743 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002743 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002743 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002743 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002743 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002743 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002743 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002743 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002743 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002743 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002743 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00002743 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001178 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002735 | 2 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002743 | 0 / 3 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001184 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002743 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002743 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002743 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002743 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002743 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002743 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002743 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002743 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002743 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002743 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002743 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002743 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002743 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002743 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00002743 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002743 | 0 / 0 |
Q9GZT4 | Serine racemase | Enzyme | C00001193 | 0 / 0 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00001184 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002743 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002743 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002743 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00002743 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002743 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002743 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002743 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002743 | 1 / 0 |
P00338 | L-lactate dehydrogenase A chain | Enzyme | C00001193 | 1 / 5 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002743 | 0 / 0 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00001193 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002743 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002743 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002743 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002743 | 1 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002743 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002743 | 2 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002743 | 0 / 1 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002743 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002743 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002743 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002743 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002743 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002743 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002743 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002743 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002743 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002743 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002743 | 0 / 0 |
Q16798 | NADP-dependent malic enzyme, mitochondrial | Enzyme | C00001193 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002743 | 3 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002743 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002743 | 5 / 1 |
Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00001343 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000113 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002743 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002743 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002743 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002743 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002743 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002743 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002743 | 1 / 1 |
Q12794 | Hyaluronidase-1 | Enzyme | C00002743 | 1 / 2 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002743 | 0 / 0 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00001184 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00002735
C00002743
|
9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 |
C00001178
C00001184
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001430
C00002743
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002743
|
182 | JAG1, AGS, AHD, AWS, CD339, HJ1, JAGL1 | jagged 1 |
C00000094
|
9818 | NUPL1, PRO2463 | nucleoporin like 1 |
C00000094
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000094
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00000094
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000094
|
9360 | PPIG, CARS-Cyp, CYP, SCAF10, SRCyp | peptidylprolyl isomerase G (cyclophilin G) (EC:5.2.1.8) |
C00000094
|
5782 | PTPN12, PTP-PEST, PTPG1 | protein tyrosine phosphatase, non-receptor type 12 (EC:3.1.3.48) |
C00000094
|
5774 | PTPN3, PTP-H1, PTPH1 | protein tyrosine phosphatase, non-receptor type 3 (EC:3.1.3.48) |
C00000094
|
6004 | RGS16, A28-RGS14, A28-RGS14P, RGS-R | regulator of G-protein signaling 16 |
C00000094
|
6016 | RIT1, NS8, RIBB, RIT, ROC1 | Ras-like without CAAX 1 |
C00000094
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00000094
|
7029 | TFDP2, DP2 | transcription factor Dp-2 (E2F dimerization partner 2) |
C00000094
|
7127 | TNFAIP2, B94, EXOC3L3 | tumor necrosis factor, alpha-induced protein 2 |
C00000094
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000094
|
7431 | VIM, CTRCT30 | vimentin |
C00000094
|
23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00002743
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002743
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002743
|
694 | BTG1 | B-cell translocation gene 1, anti-proliferative |
C00000094
|
10681 | GNB5, GB5 | guanine nucleotide binding protein (G protein), beta 5 |
C00000094
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002743
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002743
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002743
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002743
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002743
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00002743
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002743
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002743
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002743
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002743
|
440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00000094
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001193
|
55867 | SLC22A11, OAT4, hOAT4 | solute carrier family 22 (organic anion/urate transporter), member 11 |
C00001184
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001430
|
1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
C00001430
|
1572 | CYP2F1, C2F1, CYP2F | cytochrome P450, family 2, subfamily F, polypeptide 1 (EC:1.14.14.1) |
C00001430
|
1580 | CYP4B1, CYPIVB1, P-450HP | cytochrome P450, family 4, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001430
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001430
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001430
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001151
|
55630 | SLC39A4, AEZ, AWMS2, ZIP4 | solute carrier family 39 (zinc transporter), member 4 |
C00001151
|
80834 | TAS1R2, GPR71, T1R2, TR2 | taste receptor, type 1, member 2 |
C00001151
|
83756 | TAS1R3, T1R3 | taste receptor, type 1, member 3 |
C00001151
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#600807 | Asthma, susceptibility to |
Q13093
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#612933 | Glycogen storage disease xi; gsd11 |
P00338
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00069 | Glycogen storage diseases (GSD) |
P00338
(related)
|
H00010 | Multiple myeloma |
P00338
(marker)
|
H00023 | Testicular cancer |
P00338
(marker)
|
H00035 | Ewing's sarcoma |
P00338
(marker)
|
H00043 | Neuroblastoma |
P00338
(marker)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
Q13315
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D008545 | Melanoma |
C00002735
C00002743 |
D055370 | Lung Injury |
C00001430
|
D002252 | Carbon Tetrachloride Poisoning |
C00002743
|
D007249 | Inflammation |
C00002743
|
D008106 | Liver Cirrhosis, Experimental |
C00002743
|
D009203 | Myocardial Infarction |
C00002743
|
D008114 | Liver Neoplasms, Experimental |
C00001584
|
D012878 | Skin Neoplasms |
C00001584
|
D001930 | Brain Injuries |
C00001193
|
D020258 | Neurotoxicity Syndromes |
C00001193
|
D050197 | Atherosclerosis |
C00002743
|
D019969 | Amphetamine-Related Disorders |
C00001151
|
D018149 | Glucose Intolerance |
C00001151
|
D006461 | Hemolysis |
C00001151
|
D006946 | Hyperinsulinism |
C00001151
|
D006948 | Hyperkinesis |
C00001151
|
D006973 | Hypertension |
C00001151
|
D007333 | Insulin Resistance |
C00001151
|
D009401 | Nephrosis |
C00001151
|
C541083 | Non-alcoholic Fatty Liver Disease |
C00001151
|
D019966 | Substance-Related Disorders |
C00001151
|